Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-05, Stock:JNJ, The news for the past five days is as follows:
2021-01-29: NEWS1: Why Moderna Stock Surged Today.NEWS2: Tough Close To A Rough Week: Change In Tone Despite Strong Apple, Microsoft Results.NEWS3: Stock Market Today: Stocks Limp Into the Weekend.NEWS4: Dow Jones Plunges 620 Points As Apple, J&J Weigh; GameStop, AMC Stocks Surge.NEWS5: US STOCKS-Wall St drops after J&J vaccine data, GameStop effect weighs.NEWS6: J&J Slides On Less Effective Covid Vaccine; Moderna, BioNTech Pop.NEWS7: Oil Stalls for Third Week With Demand Concerns Back in Focus.NEWS8: Dow Jones Slumps 450 Points As Apple Sell-Off Continues; Bitcoin Surges, But GameStop, AMC Fade Off Highs.NEWS9: GLOBAL MARKETS-Dollar, stocks slide as virus, social trading cools sentiment.NEWS10: US STOCKS-Wall St tumbles after J&J vaccine data, GameStop effect weighs.NEWS11: Tesla Falls Below $800 as Nasdaq Swoons; Moderna Gets a Boost.NEWS12: Gold logs first gain in 7 sessions, but ends lower for the month.NEWS13: Honeywell Slips Despite 4th-Quarter Revenue Beat.NEWS14: Top Analyst Reports for Apple, Microsoft & Tesla.NEWS15: Doctor: You should take 'any vaccine that is authorized and available'.NEWS16: Everything we know about Johnson & Johnson’s single-dose Covid-19 vaccine.NEWS17: COVID SCIENCE-J&J vaccine effective in preventing severe disease; a mother's COVID-19 antibodies may protect newborns.NEWS18: Johnson & Johnson Says Its One-Dose Coronavirus Vaccine Was 66% Effective in Clinical Trial.NEWS19: US STOCKS-Wall St falls after J&J vaccine data; GameStop effect weighs.NEWS20: Doctor: COVID-19 vaccines have been the ‘highlight of our response’.NEWS21: Novavax Stock Soars as Its Covid-19 Vaccine Outperforms J&J’s.NEWS22: Vaccine Optimism Is Falling—and So Are Stocks.NEWS23: Here's where the world stands in the fight against COVID-19.NEWS24: AstraZeneca Covid-19 Vaccine Approved by EU Regulators.NEWS25: J&J Vaccine Provides Strong Shield Against Severe Covid.NEWS26: GLOBAL MARKETS-Dollar, stocks slide as virus, social trading cools sentiment.NEWS27: Gold prices rise as speculative trading worries and COVID vaccines grip market.NEWS28: Vaccine hopes boosted by data from Novavax and J&J, but fears over new variants remain.NEWS29: Johnson & Johnson's COVID-19 Vaccine Data: What You Need to Know.NEWS30: US STOCKS-Wall St falls after J&J vaccine data, hedge fund-retail investor clash.NEWS31: Pharma Stock Roundup: JNJ, NVS Q4 Earnings, MRK & LLY's Coronavirus Updates.NEWS32: Johnson & Johnson says one-dose vaccine is 72% effective in U.S..NEWS33: Moderna (MRNA) at High as Johnson & Johnson (JNJ) Vaccine Disappoints.NEWS34: J&J Vaccine Prevents Serious Illness, but Falls Short of Competitors.NEWS35: Johnson & Johnson Dips After Covid Vaccine Proves 66% Effective Overall.NEWS36: Daily U.S. Covid-19 Deaths Tick Lower.NEWS37: Johnson & Johnson Single-Dose Vaccine Found Effective Against Severe Covid-19 Infections.NEWS38: Coronavirus update: J&J vaccine 72% effective in US trial; South African strain found in US.NEWS39: Gold rises to 3-week high as speculative trading worries and COVID vaccines grip market.NEWS40: REFILE-US STOCKS-Wall St set to open lower after J&J vaccine data.NEWS41: Johnson & Johnson's COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data.NEWS42: Covid-19 Vaccine Trial Data Is Good News for Novavax.NEWS43: Wall Street falls after J&J vaccine data, hedge fund-retail investor clash.NEWS44: J&J COVID-19 vaccine is 72% effective in the U.S., and 66% overall in large trial.NEWS45: Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial.NEWS46: Better Coronavirus Stock: Johnson & Johnson vs. Pfizer.NEWS47: 3 Dividend Stocks That Could Pay You for the Rest of Your Life.NEWS48: Stocks Down but Off Lows Amid GameStop Trading Frenzy.NEWS49: Johnson & Johnson To Start With 2 Million Doses COVID-19 Vaccine Supply.NEWS50: Stocks Tumble Sharply Amid GameStop Trading Frenzy.NEWS51: Johnson & Johnson, Lilly, Caterpillar, Chevron - Friday's Premarket Movers.NEWS52: Johnson & Johnson COVID Vaccine Reaches 66% Efficacy Rate in Global Trials.NEWS53: Novavax Says Its Vaccine Is 89% Effective in Britain–but Not as Effective Against the South African Variant.
2021-02-01: NEWS1: Bank of America downgrades Moderna stock over concerns about valuation.NEWS2: Why Bank of America Thinks Moderna Stock Has Gone High Enough.NEWS3: J&J's (JNJ) Coronavirus Vaccine Shows 66% Efficacy in Phase III.NEWS4: Stock Market News for Feb 1, 2021.NEWS5: Novavax Surges On Highly Effective Covid Shot; Is NVAX Stock A Buy?.NEWS6: Earnings Parade Continues This Week With Amazon, Alphabet, PayPal And Others.NEWS7: GameStop Rallied 400% Last Week, and Two More Numbers to Know.
2021-02-02: NEWS1: Biden administration looks to directly ship vaccines to pharmacies.NEWS2: Pfizer Increased Vaccine Sales Estimate After AstraZeneca and J&J Stumbles.NEWS3: Doctor: We need to get vaccines 'in arms now to save lives'.NEWS4: UPS CEO: We have delivered 36.5 million COVID-19 vaccines.NEWS5: Russia’s Sputnik V COVID-19 vaccine shows 91.6% efficacy in late-stage trial.NEWS6: Moderna Wants to Put More Vaccine in Each Vial as Supply Challenge Changes.NEWS7: This One Stock Market Chart Will Make You a Smarter Investor.NEWS8: Will Merck (MRK) Keep the Earnings Streak Alive in Q4?.NEWS9: Doctor on coronavirus: 'We're in an arms race now'.NEWS10: New Investor in 2021? Here Are 3 Stocks to Build Your Portfolio Around.NEWS11: Is Moderna Stock a Buy or Sell After Johnson & Johnson's Vaccine News?.
2021-02-03: NEWS1: Doctor on COVID-19 progress: 'We’re definitely not out of the woods yet'.NEWS2: Coronavirus update: US hits 1M shots per day average as scientists eye second generation COVID-19 vaccines.NEWS3: GlaxoSmithKline Will Develop Next-Generation Vaccine With Biotech CureVac.NEWS4: IBD/TIPP Poll Shows Why J&J's Covid Shot Might Face An Uphill Battle.NEWS5: 3 Stocks I Can't Wait to Buy When the Stock Market Crashes Again.NEWS6: Vaccine milestone as global Covid jabs pass number of confirmed cases.
2021-02-04: NEWS1: J&J submits application for its COVID-19 shot to the FDA.NEWS2: Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate.NEWS3: IBD 50 Stocks To Watch: Emergent BioSolutions, A Biotech Stock With Solid Biodefense Cred.NEWS4: Doctor: 'It’s not about when I get vaccinated, it’s when we get vaccinated'.NEWS5: Ortho Clinical's Public Debut Proves Disappointing.NEWS6: Johnson & Johnson Seeks Emergency Use OK for Covid Vaccine.NEWS7: Novavax Surges On Highly Effective Covid Shot; Is NVAX Stock A Buy?.NEWS8: What Biden's health care priorities should be, according to experts.NEWS9: Should Investors Worry About New Coronavirus Variants?.NEWS10: Johnson & Johnson seeks US authorisation for Covid-19 vaccine.

Answer: Rise